Search

Search results

11 results found

Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease.

Saraga, Alessandra, Tina Deyhim, Ajay Gade, Grace Geeganage, Mostafa Soliman, Nathan David Vanshelboym Rothschild, Samantha Zullow, et al. 2026. “Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated With Treatment Failure in Patients With Inflammatory Bowel Disease.”. Journal of Clinical Medicine 15 (2).

Patient experience with endoscopic ultrasound and magnetic resonance cholangiopancreatography for pancreatic cancer screening (The PATRIOT study).

Merino, Andy Silva-Santisteban, Kevin Enrique Ariza Manzano, Sarah Ballou, Abraham Fourie Bezuidenhout, Katharine A Germansky, and Mandeep S Sawhney. 2026. “Patient Experience With Endoscopic Ultrasound and Magnetic Resonance Cholangiopancreatography for Pancreatic Cancer Screening (The PATRIOT Study).”. Pancreatology : Official Journal of the International Association of Pancreatology (IAP) . [et Al.] 26 (2): 259-64.

Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated with Less Treatment Failure in Patients with Inflammatory Bowel Disease Treated with Adalimumab.

Gade, Ajay, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated With Less Treatment Failure in Patients With Inflammatory Bowel Disease Treated With Adalimumab.”. Digestive Diseases and Sciences.